Goldman Sachs Group Inc. Lowers Stake in Utah Medical Products, Inc. $UTMD

Goldman Sachs Group Inc. reduced its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 3.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,286 shares of the medical instruments supplier’s stock after selling 495 shares during the quarter. Goldman Sachs Group Inc. owned approximately 0.44% of Utah Medical Products worth $801,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Jane Street Group LLC purchased a new stake in Utah Medical Products in the first quarter worth about $317,000. Huber Capital Management LLC lifted its stake in Utah Medical Products by 38.9% in the first quarter. Huber Capital Management LLC now owns 39,819 shares of the medical instruments supplier’s stock worth $2,231,000 after acquiring an additional 11,149 shares during the period. Jump Financial LLC purchased a new stake in Utah Medical Products in the first quarter worth about $370,000. Hotchkis & Wiley Capital Management LLC lifted its stake in Utah Medical Products by 35.2% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 101,640 shares of the medical instruments supplier’s stock worth $5,696,000 after acquiring an additional 26,460 shares during the period. Finally, American Century Companies Inc. lifted its stake in Utah Medical Products by 6.8% in the first quarter. American Century Companies Inc. now owns 8,690 shares of the medical instruments supplier’s stock worth $487,000 after acquiring an additional 555 shares during the period. 69.60% of the stock is owned by hedge funds and other institutional investors.

Utah Medical Products Price Performance

NASDAQ:UTMD opened at $63.01 on Wednesday. Utah Medical Products, Inc. has a 1-year low of $51.26 and a 1-year high of $68.99. The company has a 50-day moving average of $59.26 and a 200 day moving average of $56.58. The firm has a market cap of $202.26 million, a PE ratio of 16.85 and a beta of 0.32.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share for the quarter. Utah Medical Products had a net margin of 32.34% and a return on equity of 10.55%. The company had revenue of $9.95 million during the quarter.

Utah Medical Products Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 2nd. Shareholders of record on Wednesday, September 17th will be given a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 17th. Utah Medical Products’s dividend payout ratio is presently 32.62%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.